Data gathered: November 22
AI Stock Analysis - Silk Road Medical (SILK)
Analysis generated August 15, 2024. Powered by Chat GPT.
Silk Road Medical is a medical technology company dedicated to reducing the risk of stroke through minimally invasive techniques. The company is known for its innovative procedures that aim to enhance the safety and efficacy of vascular surgery. The primary product, the TCAR system, is designed for carotid artery revascularization in patients at high risk for adverse events from traditional surgical techniques.
Stock Alerts - Silk Road Medical (SILK)
 |
Silk Road Medical | November 12 Employee Rating is up by 2.2% over the last month. |
|
Silk Road Medical | November 12 Business Outlook among employees is down by -14.8% over the last month. |
|
Silk Road Medical | November 8 Sentiment is down by 24.8% in the last couple of days. |
|
Silk Road Medical | November 8 Reddit mentions are up by 756% in the last 24h. |
Alternative Data for Silk Road Medical
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 1 | Sign up | Sign up | Sign up |
| Sentiment | 58 | Sign up | Sign up | Sign up |
| Webpage traffic | 6,000 | Sign up | Sign up | Sign up |
| Employee Rating | 92 | Sign up | Sign up | Sign up |
| Google Trends | 4 | Sign up | Sign up | Sign up |
| Patents | 72 | Sign up | Sign up | Sign up |
| 4chan Mentions | 2 | Sign up | Sign up | Sign up |
| Facebook Engagement | 47 | Sign up | Sign up | Sign up |
| Facebook Followers | 802 | Sign up | Sign up | Sign up |
| Reddit Mentions | 11 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 652 | Sign up | Sign up | Sign up |
| Twitter Followers | 1,357 | Sign up | Sign up | Sign up |
| Twitter Mentions | 23 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 1,380 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| ESG | 39 | Sign up | Sign up | Sign up |
| Business Outlook | 75 | Sign up | Sign up | Sign up |
| Linkedin Employees | 445 | Sign up | Sign up | Sign up |
About Silk Road Medical
Silk Road Medical, Inc. develops and manufactures medical devices to treat neurovascular diseases. The firm's devices enable vascular access via a puncture adjacent to the collarbone instead of the traditional approach of accessing the vascular system through the groin.
| Price | $27.49 |
| Target Price | Sign up |
| Volume | 2,310,000 |
| Market Cap | $1.12B |
| Year Range | $15.85 - $27.5 |
| Dividend Yield | 0% |
| Analyst Rating | 0% buy |
| Industry | Medical & Dental Instruments |
In the news
 |
Silk Road Medical, Inc (NASDAQ:SILK) Given Consensus Rating of “Reduce” by BrokeragesOctober 3 - ETF Daily News |
[Latest] Global Embolic Protection Device Market Size/Share Worth USD 3,562.2 Million by 2033 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)October 28 - GlobeNewswire |
|
 |
Earnings call: Boston Scientific reports robust Q3 growth, raises outlookOctober 23 - Investing.com |
 |
Top 6 Growth Stocks For The Next 10 YearsOctober 16 - Forbes |
 |
Baird raises Boston Scientific stock target, rating held on strong Q3 outlookOctober 15 - Investing.com |
|
Boston Scientific stock hits all-time high at $84.89October 7 - Investing.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '24 | 51M | 57M | 39M | -17M | -17M | -0.420 |
| Q1 '24 | 47M | 53M | 37M | -14M | -14M | -0.360 |
| Q4 '23 | 46M | 52M | 35M | -13M | -14M | -0.330 |
| Q3 '23 | 43M | 48M | 32M | -13M | -13M | -0.330 |
| Q2 '23 | 44M | 49M | 32M | -13M | -14M | -0.350 |
Insider Transactions View All
| Klemz Kevin M filed to sell 162,926 shares at $27.1. August 21 '24 |
| Davis Andrew S. filed to sell 289,707 shares at $27. July 8 '24 |
| Klemz Kevin M filed to sell 165,194 shares at $17.2. March 5 '24 |
| Jones Marie L. filed to sell 76,894 shares at $17.2. March 5 '24 |
| Davis Andrew S. filed to sell 287,773 shares at $17.2. March 5 '24 |
Similar companies
Read more about Silk Road Medical (SILK) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Silk Road Medical?
The Market Cap of Silk Road Medical is $1.12B.
What is the current stock price of Silk Road Medical?
Currently, the price of one share of Silk Road Medical stock is $27.49.
How can I analyze the SILK stock price chart for investment decisions?
The SILK stock price chart above provides a comprehensive visual representation of Silk Road Medical's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Silk Road Medical shares. Our platform offers an up-to-date SILK stock price chart, along with technical data analysis and alternative data insights.
Does SILK offer dividends to its shareholders?
As of our latest update, Silk Road Medical (SILK) does not offer dividends to its shareholders. Investors interested in Silk Road Medical should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Silk Road Medical?
Some of the similar stocks of Silk Road Medical are Align Technology, Dentsply, LeMaitre Vascular, iRhythm Technologies, and NovoCure.
.